Literature DB >> 3430270

Efficacy of oral rehydration solutions in a rat model of secretory diarrhea.

D D Rolston1, M M Borodo, M J Kelly, A M Dawson, M J Farthing.   

Abstract

Controversy continues regarding the ideal composition of glucose/electrolyte solutions used for oral rehydration of infants and children with acute diarrhea. We have used cholera toxin-treated rat small intestine as a model of secretory diarrhea to assess the efficacy of oral rehydration solutions by intestinal perfusion. All solutions tested reversed net water secretion but a hypotonic bicarbonate-free solution was more effective than other solutions, including the World Health Organization oral rehydration solution (p less than 0.003). Net sodium secretion persisted with all solutions tested but there was a significant linear relationship between sodium concentration of the solution perfused and net sodium transport (r = 0.75, p less than 0.05). Cholera toxin treatment alone and in combination with perfusion of oral rehydration solutions significantly reduced plasma sodium concentration and osmolality (p less than 0.05), the effects being most marked with low sodium solutions. Although direct parallelism between observations in this animal model of secretory diarrhea and human diarrheal disease has not been established as yet, the model may be useful in assessing clinical efficacy of new oral rehydration solutions and in systematic analysis of the relative benefits of their individual components.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3430270     DOI: 10.1097/00005176-198707000-00023

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  22 in total

Review 1.  Sodium content of oral rehydration solutions: a reappraisal.

Authors:  E J Elliott; R Cunha-Ferreira; J A Walker-Smith; M J Farthing
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

2.  Effect of base precursors on water and electrolyte transport during oral hydration solution perfusion in secreting rat intestine.

Authors:  D D Rolston; V I Mathan
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

3.  Inhibitory effect of luminal saccharides on glucose absorption from an adjacent jejunal site in rats: a newly described intestinal neural reflex.

Authors:  Fadi H Mourad; Kassem A Barada; Nayef E Saade
Journal:  Pflugers Arch       Date:  2018-11-06       Impact factor: 3.657

4.  Effect of antisecretory factor on Escherichia coli STa enterotoxin-induced alkalinisation of pig jejunal acid microclimate.

Authors:  G T McEwan; B Schousboe; E Skadhauge
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

5.  Proabsorptive and prosecretory roles for nitric oxide in cholera toxin induced secretion.

Authors:  J L Turvill; F H Mourad; M J Farthing
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

6.  Cisplatin impairs fluid and electrolyte absorption in rat small intestine: a role for 5-hydroxytryptamine.

Authors:  C P Bearcroft; P Domizio; F H Mourad; E A André; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 7.  Fluid and carbohydrate replacement during intermittent exercise.

Authors:  X Shi; C V Gisolfi
Journal:  Sports Med       Date:  1998-03       Impact factor: 11.136

8.  Acetate absorption in the normal and secreting rat jejunum.

Authors:  A J Watson; E J Elliott; D D Rolston; M M Borodo; M J Farthing; P D Fairclough
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

Review 9.  History and rationale of oral rehydration and recent developments in formulating an optimal solution.

Authors:  M J Farthing
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins.

Authors:  F H Mourad; L J O'Donnell; J A Dias; E Ogutu; E A Andre; J L Turvill; M J Farthing
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.